Neurocrine and Idorsia End Partnership Following Phase 2 Trial Failures of Epilepsy Drug
After two years and multiple unsuccessful trials, Neurocrine Biosciences and Swiss biotech Idorsia have officially ended their collaboration on NBI-827104, ...
After two years and multiple unsuccessful trials, Neurocrine Biosciences and Swiss biotech Idorsia have officially ended their collaboration on NBI-827104, ...
© 2020 The Lagos Today - Nkali.